Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Yi-Hong Zhou, Yumay Chen, Yuanjie Hu, Liping Yu, Katherine Tran, Erich Giedzinski, Ning Ru, Alex Gau, Francine Pan, Jiao Qiao, Naomi Atkin, Khang Chi Ly, Nathan Lee, Eric R. Siegel, Mark E. Linskey, Ping Wang, Charles Limoli
Published Sep 8, 2017 · Vol. 8, No. 46 · pp. 80853-80868
Bing Zhu, Ashley Lindsey, Nan Li, Kevin Lee, Veronica Ramirez-Alcantara, Joshua C. Canzoneri, Alexandra Fajardo, Luciana Madeira da Silva, Meagan Thomas, John T. Piazza, Larry Yet, Brian T. Eberhardt, Evrim Gurpinar, Dennis Otali, William Grizzle, Jacob Valiyaveettil, Xi Chen, Adam B. Keeton, Gary A. Piazza
Published Aug 27, 2017 · Vol. 8, No. 41 · pp. 69264-69280